India News: Russia on Monday hoped that the Drug Controller General of India (DCGI) will soon complete the approval process for the Sputnik-V coronavirus vaccine
Remdesivir has no impact on Covid mortality, don t panic-buy: Doctors
SECTIONS
Share
Synopsis
The rush to secure doses of the antiviral remdesivir is unfounded as it has little or no impact on survival in those hospitalised with Covid-19, leading doctors and members of the state task force have said.
Agencies
In guidelines issued last year, the Indian Council of Medical Research (ICMR) said the intravenous drug cannot be used as standard care and remains beneficial only if used during the first 10 days of infection.
(This story originally appeared in on Apr 11, 2021)The rush to secure doses of the antiviral remdesivir is unfounded as it has little or no impact on survival in those hospitalised with Covid-19, leading doctors and members of the state task force have said.
Updated Apr 8, 2021, 8:46 am IST
This change in the government’s plan comes as the desired target for vaccinations is yet to be achieved
Union health secretary Rajesh Bhushan said this was done since a substantial proportion of the 45-plus population are in the organised sector of the economy and work in offices (private or government), or in manufacturing and services. (Representational Photo: AP)
New Delhi: In a bid to increase the Covid-19 vaccination coverage, the Centre on Wednesday allowed private companies to vaccinate their employees at workplaces from April 11.
In a letter to all states/Union territories, Union health secretary Rajesh Bhushan said this was done since a substantial proportion of the 45-plus population are in the organised sector of the economy and work in offices (private or government), or in manufacturing and services. He added that to increase access to vaccines for such people, Covid-19 sessions may be held at workplaces that have 100 or more wil
India News: BHOPAL: Half a dozen more vaccines are on the horizon and will be introduced to fight against Covid-19, said Union minister of health and family welfa.
Bharat Biotech s nasal Covid-19 vaccine trials likely to begin next week: Sources
Bharat Biotech s nasal Covid-19 vaccine trials likely to begin next week: Sources
The process of recruiting participants for these trails is underway. The trails will be held in Patna, Chennai, Hyderabad and Nagpur.
advertisement
(Representational image. Photo: AFP)
These trails will be conducted in Patna, Chennai, Nagpur and Hyderabad.
As per the Central Trail Registry of India (CTRI), these trials will be conducted on 175 participants.
Sources have told India Today TV that the process of recruiting participants for these trails is underway and the ethics committees of these trial sites are yet to grant approval.